Navigation Links
UCLA study identifies 2 chemicals that could lead to new drugs for genetic disorders
Date:9/28/2009

UCLA scientists have identified two chemicals that convince cells to ignore premature signals to stop producing important proteins. Published in the Sept. 28 edition of the Journal of Experimental Medicine, the findings could lead to new medications for genetic diseases, such as cancer and muscular dystrophy, that are sparked by missing proteins.

"When DNA changes, such as nonsense mutations, occur in the middle rather than the end of a protein-producing signal, they act like a stop sign that tells the cell to prematurely interrupt protein synthesis," explained Dr. Richard Gatti, professor of pathology and laboratory medicine and human genetics at the David Geffen School of Medicine at UCLA. "These nonsense mutations cause the loss of vital proteins that can lead to deadly genetic disorders."

Gatti's lab specializes in studying ataxia-telangiectasia (A-T), a progressive neurological disease that strikes young children, often killing them by their late teens or early 20s.

For four years, the UCLA Molecular Shared Screening Resources Center of the campus' California NanoSystems Institute has screened 35,000 chemicals, searching for those that ignore premature stop signals.

First author Liutao Du developed the screening technology in Gatti's laboratory.

"Of the dozens of active chemicals we discovered, only two were linked to the appearance and function of ATM, the protein missing from the cells of children with A-T," said Du. "These two chemicals also induced the production of dystrophin, a protein that is missing in the cells of mice with a nonsense mutation in the muscular dystrophy gene."

The UCLA team is optimistic that their discovery will aid pharmaceutical companies in creating drugs that correct genetic disorders caused by nonsense mutations. This could affect one in five patients with most genetic diseases, including hundreds of thousands of people suffering from incurable diseases. Because nonsense mutations can lead to cancer, such drugs may also find uses in cancer treatment.


'/>"/>

Contact: Elaine Schmidt
eschmidt@mednet.ucla.edu
310-794-2272
University of California - Los Angeles
Source:Eurekalert

Related medicine news :

1. New study resolves the mysterious origin of Merkel cells
2. Many Kids Suffer Medication Side Effects: Study
3. Swiss study finds income affects prostate cancer patients survival
4. Study finds intervention program increases kids healthy eating, reduces screen time
5. Exercise May Prevent Prostate Cancer: Study
6. Video: Despite Increased Health Threat, New Study Finds Low Concern About Flu Among Hispanics
7. New England Journal of Medicine Also Publishes Mayo Clinic Study of Physicians Beliefs About Health Care Reform
8. New England Journal of Medicine publishes Mayo Clinic study about health care reform
9. HIV vaccine regimen demonstrates modest preventive effect in Thailand clinical study
10. Volcano Corporation Praises FAME Study Results
11. Study reveals 2/3 of prostate cancer patients do not need treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... Gables, FL (PRWEB) , ... May 25, 2016 ... ... its Cross Benefit Clearinghouse supporting the real time adjudication of medical service claims ... Care providers using their current medical claims management software. The TransactRx Cross Benefit ...
(Date:5/25/2016)... ... ... America Walks , a national advocacy organization that promotes walking and ... Pittsburgh Graduate School of Public Health , has been awarded a Walking College ... around the country to participate in a four-month training program designed to strengthen local ...
(Date:5/25/2016)... ... May 25, 2016 , ... BeniComp ... a significant spike in their clients' employee participation for their wellness initiatives. ... by implementing a high-deductible health plan with outcome-based deductible incentives. As a result, ...
(Date:5/25/2016)... ... May 25, 2016 , ... ... announced that it will join America's leading engineers at the American Society of ... the Georgia World Congress Center. , Engineers, speakers and exhibitors from more ...
(Date:5/24/2016)... ... , ... Sterling Global Products is launching a Kickstarter campaign focused on “PAW ... The campaign kick-off video is located via this link https://youtu.be/WsO4qz2odco . The campaign ... to raise $1,000 per day for a total of $25,000. The funds will be ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... Texas , May 25, 2016 ... the issuance to it by the US Patent ... The company,s technology includes proprietary processes for electronic ... for health and wellness programs, HIPAA compliance and ... "Our technology ...
(Date:5/24/2016)... , May 24, 2016 Cirujanos ... para ayudar a los médicos a compartir sus mejores ... a escala mundial. Profesionales médicos de Europa, África, ... han apuntado a la aplicación, que combina la transmisión ... entorno totalmente seguro. Educación   "Imagine ...
(Date:5/24/2016)... LAWRENCE, Mass. , May 24, 2016  NxStage ... medical technology company focused on advancing renal care, today ... Officer, plans to participate in the following schedule of ... will be made available at http://ir.nxstage.com/ . ... Jefferies Healthcare Conference NY, NY           Friday, ...
Breaking Medicine Technology: